255
Views
5
CrossRef citations to date
0
Altmetric
Letters to the Editor

Serological response following vaccination with BNT162b2 mRNA in patients with chronic lymphocytic leukemia

, , & ORCID Icon
Pages 503-505 | Received 12 Jul 2021, Accepted 16 Aug 2021, Published online: 02 Nov 2021
 

Disclosure statement

C. da Cunha-Bang received consultancy fees and/or travel grants outside the current study from Astra Zeneca, Abbvie, and Gilead. C. U. Niemann has received research funding and/or consultancy fees from Abbvie, AstraZeneca, Janssen, CSL Behring, Takeda and the Novo Nordisk Foundation.

Additional information

Funding

This work was supported by Novo Nordisk Foundation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.